ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
0.9501
-0.0699 (-6.85%)
At close: Aug 10, 2026, 4:00 PM EDT
0.9491
-0.0010 (-0.11%)
After-hours: Aug 10, 2026, 5:04 PM EDT
ABVC BioPharma Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
19
Market Cap
24.01M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 509.59K | 357.16K | 234.31% |
| Dec 31, 2023 | 152.43K | -817.35K | -84.28% |
| Dec 31, 2022 | 969.78K | 613.99K | 172.57% |
| Dec 31, 2021 | 355.80K | -127.25K | -26.34% |
| Dec 31, 2020 | 483.05K | -218.67K | -31.16% |
| Dec 31, 2019 | 701.72K | 694.76K | 9,987.97% |
| Dec 31, 2018 | 6.96K | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | 988.15K | - | - |
| Sep 30, 2016 | - | - | - |
| Sep 30, 2015 | 3.36K | -4.43K | -56.85% |
| Sep 30, 2013 | 7.79K | 2.07K | 36.28% |
| Sep 30, 2012 | 5.71K | 2.52K | 79.12% |
| Sep 30, 2011 | 3.19K | -11.67K | -78.53% |
| Sep 30, 2010 | 14.86K | - | - |
| Sep 30, 2009 | - | - | - |
| Sep 30, 2008 | 25.09K | -16.58K | -39.78% |
| Sep 30, 2007 | 41.67K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Actinium Pharmaceuticals | 35.09M |
| Barinthus Biotherapeutics | 14.97M |
| Evaxion | 7.53M |
| Kyntra Bio | 7.44M |
| Longeveron | 1.22M |
| IGC Pharma | 1.11M |
| Allarity Therapeutics | 345.00K |
ABVC News
- 7 days ago - ABVC Biopharma Inc trading halted, news pending - TheFly
- 13 days ago - ABVC BioPharma Proxy statement: Proxy filing - Filings
- 3 months ago - ABVC BioPharma Quarterly report: Q1 2026 - Filings
- 5 months ago - ABVC BioPharma Proxy statement: Proxy Filing - Filings
- 5 months ago - ABVC BioPharma Annual report: Q4 2025 - Filings
- 6 months ago - ABVC BioPharma Proxy statement: Proxy Filing - Filings
- 10 months ago - ABVC BioPharma Earnings release: Q3 2025 - Filings
- 10 months ago - ABVC BioPharma Quarterly report: Q3 2025 - Filings